$4.11
-0.02-0.48%
Pre-Market: Jul 2, 5:22 PM EDT
15 minutes delayed
Cormedix
CRMDNASDAQ
want to know what
the Bulls & Bears Say?
Cormedix (NASDAQ:CRMD) Stock, Analyst Ratings, Price Targets, Forecasts
Cormedix Inc has a consensus price target of $13.6 based on the ratings of 24 analysis. The 3 most-recent analyst ratings were released by Needham, Needham, and JMP Securities on June 19, 2024, May 13, 2024, and April 9, 2024, respectively. With an average price target of $13 between Needham, Needham, and JMP Securities, there's an implied 216.30% upside for Cormedix Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Needham
JMP Securities
RBC Capital
Truist Securities
JMP Securities
1calculated from analyst ratings
Analyst Ratings for Cormedix
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/19/2024 | Buy Now | 143.31% | Needham | Serge Belanger | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | 143.31% | Needham | Serge Belanger | → $10 | Reiterates | Buy → Buy | Get Alert |
| 04/09/2024 | Buy Now | 362.29% | JMP Securities | Jason Butler | → $19 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/09/2024 | Buy Now | 143.31% | Needham | Serge Belanger | → $10 | Reiterates | Buy → Buy | Get Alert |
| 03/13/2024 | Buy Now | 118.98% | RBC Capital | Gregory Renza | $10 → $9 | Maintains | Outperform | Get Alert |
| 03/12/2024 | Buy Now | 143.31% | Needham | Serge Belanger | $10 → $10 | Maintains | Buy | Get Alert |
| 01/31/2024 | Buy Now | 240.63% | Truist Securities | Joon Lee | $18 → $14 | Maintains | Buy | Get Alert |
| 11/15/2023 | Buy Now | 143.31% | Needham | Serge Belanger | $12 → $10 | Maintains | Buy | Get Alert |
| 11/15/2023 | Buy Now | 143.31% | RBC Capital | Gregory Renza | $6 → $10 | Maintains | Outperform | Get Alert |
| 11/15/2023 | Buy Now | 337.96% | Truist Securities | Joon Lee | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 11/15/2023 | Buy Now | 362.29% | JMP Securities | Jason Butler | → $19 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/10/2023 | Buy Now | 45.99% | RBC Capital | Gregory Renza | → $6 | Initiates | → Outperform | Get Alert |
| 08/08/2023 | Buy Now | 191.97% | Needham | Serge Belanger | $13 → $12 | Maintains | Buy | Get Alert |
| 06/21/2023 | Buy Now | 216.3% | Needham | Serge Belanger | → $13 | Reiterates | Buy → Buy | Get Alert |
| 05/19/2023 | Buy Now | 362.29% | JMP Securities | Jason Butler | $16 → $19 | Maintains | Market Outperform | Get Alert |
| 05/16/2023 | Buy Now | 216.3% | Needham | Serge Belanger | → $13 | Reiterates | Buy → Buy | Get Alert |
| 03/31/2023 | Buy Now | 289.29% | JMP Securities | Jason Butler | → $16 | Reiterates | → Market Outperform | Get Alert |
| 03/31/2023 | Buy Now | 216.3% | Needham | Serge Belanger | → $13 | Reiterates | → Buy | Get Alert |
| 03/03/2023 | Buy Now | 216.3% | Needham | Serge Belanger | → $13 | Reiterates | → Buy | Get Alert |
| 03/01/2023 | Buy Now | 289.29% | JMP Securities | Roy Buchanan | $14 → $16 | Maintains | Market Perform | Get Alert |
| 11/11/2022 | Buy Now | 216.3% | Needham | Serge Belanger | $12 → $13 | Maintains | Buy | Get Alert |
| 08/12/2022 | Buy Now | 289.29% | Truist Securities | Joon Lee | $27 → $16 | Maintains | Buy | Get Alert |
| 08/09/2022 | Buy Now | 240.63% | JMP Securities | Jason Butler | $19 → $14 | Maintains | Market Outperform | Get Alert |
| 08/09/2022 | Buy Now | 191.97% | Needham | Serge Belanger | $20 → $12 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Cormedix (CRMD) stock?
The latest price target for Cormedix (NASDAQ:CRMD) was reported by Needham on June 19, 2024. The analyst firm set a price target for $10.00 expecting CRMD to rise to within 12 months (a possible 143.31% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cormedix (CRMD)?
The latest analyst rating for Cormedix (NASDAQ:CRMD) was provided by Needham, and Cormedix reiterated their buy rating.
When was the last upgrade for Cormedix (CRMD)?
There is no last upgrade for Cormedix
When was the last downgrade for Cormedix (CRMD)?
There is no last downgrade for Cormedix.
When is the next analyst rating going to be posted or updated for Cormedix (CRMD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cormedix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cormedix was filed on June 19, 2024 so you should expect the next rating to be made available sometime around June 19, 2025.
Is the Analyst Rating Cormedix (CRMD) correct?
While ratings are subjective and will change, the latest Cormedix (CRMD) rating was a reiterated with a price target of $10.00 to $10.00. The current price Cormedix (CRMD) is trading at is $4.11, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.